May 11, 2026

Bowel Management Reduced Wet Days

Adding urotherapy at treatment initiation was not associated with additional benefit over 12 weeks

Conexiant

May 11, 2026

Ultrasound Attenuation Imaging Tracks Hepatic Steatosis

Attenuation imaging increased with visually graded steatosis severity in pediatric patients, but findings were not validated against MRI-PDFF or biopsy.

Conexiant

May 11, 2026

Health, Social Needs Tied to Absences

National survey data suggest overlapping chronic health and social needs are associated with higher rates of illness-related missed school days among US children.

Conexiant

April 29, 2026

FDA Reports Results of Nationwide Infant Formula Testing

Federal testing survey examines chemical contaminant profiles across widely used products

Conexiant

April 29, 2026

Side Effects: The Stuff We Ignore

An anal fissure masquerading as hemorrhoid pain. A spouse's family history predicting your survival. Melatonin labels lying about their own dosage. This week's studies reward the clinician who looks twice.

Conexiant

April 13, 2026

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Conexiant

April 15, 2025

AGA unveils annual recognition award recipients

The honorees reflect the best of the specialty, from groundbreaking research to outstanding patient care and leadership.

The New Gastroenterologist

May 01, 2024

Chronic Liver Disease in Latinx Pediatric Patients: Risk Factor Potentially Identified as Cases Rise

Investigators may have uncovered a new factor contributing to the rising incidence of metabolic dysfunction–associated steatotic liver disease among Latinx pediatric patients.

Conexiant

November 06, 2024

Weekend Warriors: New Hope for Busy Docs

Almost half of surgeons miss exercise guidelines, but research shows "weekend warriors" achieve similar cardiovascular benefits to those who exercise daily.

Conexiant

November 01, 2024

Study: U.S. Faces Higher Drug Shortages

A recent study compared drug shortage risks between the U.S. and Canada, revealing that the U.S. experienced approximately a 40% higher drug shortage risk compared to Canada, with trends persisting both pre-pandemic and during COVID-19. The study highlighted that Canada's approach was associated with a lower shortage risk.

Conexiant